Impregnation of Ultrahigh-Molecular-Weight Polyethylene with Amoxicillin in Subcritical Freon R22 Media
- Autores: Zalepugin D.Y.1, Maksimkin A.V.2, Kiselevsky M.V.2,3, Tilkunova N.A.1, Anisimova N.Y.2,3, Chernyshova I.V.1, Spirina T.S.3, Senatov F.S.2, Vlasov M.I.1
-
Afiliações:
- Federal State Unitary Enterprise State Plant of Medicinal Drugs
- National University of Science and Technology MISiS
- Blokhin Russian Cancer Research Center
- Edição: Volume 11, Nº 8 (2017)
- Páginas: 1215-1222
- Seção: Article
- URL: https://journals.rcsi.science/1990-7931/article/view/199815
- DOI: https://doi.org/10.1134/S1990793117080152
- ID: 199815
Citar
Resumo
The method of impregnation of ultrahigh-molecular-weight polyethylene (UHMWPE) with amoxicillin in subcritical Freon R22 media is developed. For the first time, the possibility of polymer impregnation with a polar substance (a standard antibiotic amoxicillin) in the absence of cosolvents is shown. Cosolvents increase the polarity of the medium and removal of them from the polymer matrix is usually a serious problem. Amoxicillin desorption curves from the impregnated UHMWPE samples are obtained by high-performance liquid chromatography (HPLC). Polymeric samples impregnated with amoxicillin are active against gram-positive and gram-negative microorganisms S. aureus, S. epidermidis, E. faecalis, B. subtilis, and E. coli, allowing them to be considered as real implant models for replacement of bone tissue.
Palavras-chave
Sobre autores
D. Zalepugin
Federal State Unitary Enterprise State Plant of Medicinal Drugs
Autor responsável pela correspondência
Email: zaledmit@gmail.com
Rússia, Moscow, 111024
A. Maksimkin
National University of Science and Technology MISiS
Email: zaledmit@gmail.com
Rússia, Moscow, 119049
M. Kiselevsky
National University of Science and Technology MISiS; Blokhin Russian Cancer Research Center
Email: zaledmit@gmail.com
Rússia, Moscow, 119049; Moscow, 115478
N. Tilkunova
Federal State Unitary Enterprise State Plant of Medicinal Drugs
Email: zaledmit@gmail.com
Rússia, Moscow, 111024
N. Anisimova
National University of Science and Technology MISiS; Blokhin Russian Cancer Research Center
Email: zaledmit@gmail.com
Rússia, Moscow, 119049; Moscow, 115478
I. Chernyshova
Federal State Unitary Enterprise State Plant of Medicinal Drugs
Email: zaledmit@gmail.com
Rússia, Moscow, 111024
T. Spirina
Blokhin Russian Cancer Research Center
Email: zaledmit@gmail.com
Rússia, Moscow, 115478
F. Senatov
National University of Science and Technology MISiS
Email: zaledmit@gmail.com
Rússia, Moscow, 119049
M. Vlasov
Federal State Unitary Enterprise State Plant of Medicinal Drugs
Email: zaledmit@gmail.com
Rússia, Moscow, 111024
Arquivos suplementares
